Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
Alicia Rodríguez-Gascón, Ana del Pozo-Rodríguez, María Ángeles SolinísPharmacokinetic, Nanotechnology and Gene Therapy Group (PharmaNanoGene), Faculty of Pharmacy, Centro de Investigación Lascaray Ikergunea, University of...
Guardado en:
Autores principales: | Rodríguez-Gascón A, del Pozo-Rodríguez A, Solinís MA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cdedf95e144a4b0fa591a86673911f5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
por: Angel Rodríguez, et al.
Publicado: (2010) -
Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles
por: Héctor L Rodríguez-Luccioni, et al.
Publicado: (2011) -
Efficacy and safety of chondroitin sulfate/xanthan gum versus polyethylene glycol/propylene glycol/hydroxypropyl guar in patients with dry eye
por: Llamas-Moreno JF, et al.
Publicado: (2013) -
Bilateral idiopathic orbital inflammation 3 years before systemic Wegener´s granulomatosis in a 7-year-old girl
por: Juan D Martínez-Gutiérrez, et al.
Publicado: (2008) -
Epidemiological support for genetic variability at hypothalamic–pituitary–adrenal axis and serotonergic system as risk factors for major depression
por: Ching-López A, et al.
Publicado: (2015)